Skip to main content
. 2023 Feb 3;10(2):1372–1384. doi: 10.1002/ehf2.14290

Figure 2.

Figure 2

Casemix standardized risk ratio for prescription in STEMI survivor due to heart failure status between the MINAP and JROAD‐DPC. STEMI, ST‐elevation myocardial infarction; UK, United Kingdom; ACE‐I/ARB, angiotensin angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist; CI, confidence interval.